BIXT Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 21:35):

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans...

Stats
Dagens volum	91 490.00
Gjennomsnittsvolum	106 849
Markedsverdi	15.85M
EPS	$-0.00734 ( 2023-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.65
ATR14	$0.00600 (5.48%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-19	Milanova Radka	Buy	70 423	common
2024-04-19	Conaway Dale H	Buy	70 423	common
2024-04-19	Hoberman Alan M	Buy	70 423	common
2024-04-19	Milanova Radka	Sell	0	common
2024-03-27	Utter Anders	Buy	266 955	common

INSIDER POWER
89.94
Last 84 transactions
Buy: 33 376 843 \| Sell: 11 429 961

Bioxytran, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Bioxytran, Inc. Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$-3 644.00 (0.00 %)
EPS:	$-0.0214

FY	2022
Omsetning:	$0
Bruttogevinst:	$-3 644.00 (0.00 %)
EPS:	$-0.0214

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.0420

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.0271

Financial Reports:

No articles found.

Bioxytran, Inc.

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.